Thomas Ernst, PD Dr. med.
1 clinical trials · Sponsor
◉ Watch Thomas Ernst, PD Dr. med.
| Record | Firm | Date |
|---|---|---|
| Venetoclax After TKI to Target Persisting Stem Cells in CML (NCT05701215) | Thomas Ernst, PD Dr. med. | 2023-08-31 |
Track Thomas Ernst, PD Dr. med. automatically
Every clearance here is in the API, with alerts when new ones post.